Rosenblatt Reiterates Buy on Imax, Maintains $30 Price Target
Portfolio Pulse from Benzinga Newsdesk
Rosenblatt analyst Steve Frankel has reiterated a 'Buy' rating on Imax (NYSE:IMAX) and maintained a price target of $30.
October 10, 2023 | 11:16 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Rosenblatt analyst Steve Frankel has reiterated a 'Buy' rating on Imax and maintained a price target of $30.
The reiteration of a 'Buy' rating by a Rosenblatt analyst and the maintenance of a $30 price target indicates a positive outlook for Imax. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100